A2Z Smart Technologies Corp. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
TEL AVIV, ISRAEL / ACCESSWIRE / March 21, 2024 / A2Z Smart Technologies Corp. (the "Company" or "A2Z") (NASDAQ:AZ), a...
Month: March 2024
Amesite Announces Strategic Five-Year Partnership with Volunteer State Community College to Expand Technical Workforce
Vol State is Fifth Contract Win Since Introducing No Setup-fee Plan DETROIT, MI / ACCESSWIRE / March 21, 2024 /...
Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
-- Povetacicept demonstrates greater reductions in disease activity in a mouse model of lupus compared to WT TACI-Ig or B...
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
Initiated IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibodyEntered into collaboration with AstraZeneca for up to $247M in deal...
XOMA Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board...
XOMA Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board...
XOMA Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board...
Theratechnologies entreprend l’augmentation de la dose dans l’essai clinique de phase I sur le sudocétaxel zendusortide dans le traitement du cancer de l’ovaire avancé
MONTRÉAL, 21 mars 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique...
SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023
Conference Call and Live Audio Webcast Scheduled for Thursday, March 21, 2024, at 10:00 a.m. ET Corporate Highlights Fourth quarter...
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
PYX-201 Phase 1 Part 1 trial progressing with initial data expected in the fall of 2024PYX-106 Phase 1 trial progressing...
Nano Dimension Announces Record 2023 Revenue of $56.3 Million and Organic Growth of 29%
Gross Margin Grew 41%; 45% vs. 32% Year-Over-YearRead more at globenewswire.com
La plateforme unique de nCino sélectionnée par Desjardins pour automatiser le processus d’origination de prêts grâce à l’apprentissage automatique
QUÉBEC, 21 mars 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ : NCNO), un pionnier dans le domaine de la banque...
Intuitive Machines Reports Fourth Quarter and Full Year 2023 Financial Results
HOUSTON, March 21, 2024 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space...
Intuitive Machines Reports Fourth Quarter and Full Year 2023 Financial Results
HOUSTON, March 21, 2024 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space...
FirstService Corporation Announces Upcoming Meeting and Financial Reporting Dates
Annual Meeting of Shareholders on April 3, 2024Release of First Quarter 2024 Results on April 24, 2024TORONTO, March 21, 2024...
BTQ Technologies Announces Christopher Tam as Featured Speaker at ETHTaipei
VANCOUVER, BC, March 21, 2024 /PRNewswire/ - BTQ Technologies Corp. (the "Company" or "BTQ") (NEO: BTQ) (OTCQX: BTQQF) (FSE: NG3),...
IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results
SAINT LAURENT, Quebec, March 21, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results...
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update
- On track to resubmit NDA for etripamil in PSVT early 2Q 2024- Recent financing extends cash runway into 2026-...
FaZe Clan is Building a Licensing Empire at Retailers Across the Nation
FaZe's Success Builds on Innovative Dual Revenue Model Generating Over $75 Million in Licensed Products LOS ANGELES, CA / ACCESSWIRE...
U.S. Energy Corp. Announces Fourth Quarter and Year End 2023 Results Conference Call Date
HOUSTON, March 21, 2024 (GLOBE NEWSWIRE) -- U.S. Energy Corp. (NASDAQ: USEG, or the “Company”), a growth-focused energy company engaged...
Telesat Fourth Quarter 2023 Earnings Conference Call
OTTAWA, March 21, 2024 (GLOBE NEWSWIRE) -- Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative...
Redecan Cannabis Launches New Spring Lineup
TORONTO, March 21, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer...
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
MALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on...
POET to Demo AI Hardware Products for 800G and Beyond at OFC 2024
TORONTO and SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK;...
Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report
HAIFA, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company...
OKYO Pharma to Host Key Opinion Leader Event to Discuss New and Comprehensive Data from Phase 2 Dry Eye Disease Trial
-Phase 2 OK-101 efficacy data to be released March 22nd, 2024--KOL Event to be held on April 9th, 2024 at...
Mercury Systems and Lockheed Martin to Advance Defense Manufacturing Capabilities in Switzerland
GENEVA, March 21, 2024 (GLOBE NEWSWIRE) -- Mercury Mission Systems International SA (www.mrcy.com), a technology company that delivers mission-critical processing...
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
– Enrollment in the two pivotal trials of lorundrostat for the treatment of uHTN or rHTN is on track, with...
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
$19 million revenue in 2023; $24 million projected revenue in 2024NexoBrid® commercially launched in U.S., Japan, IndiaPotential blockbuster EscharEx® to...
Laser Photonics Corporation Enters Distribution Agreement With Incredible Supply & Logistics for Its Military & Industrial Laser Solutions
Contacts Investor Relations Contact: laser@haydenir.com Media Contact: Karla Kizzort Marketing Specialist Laser Photonics Corporation kkizzort@laserphotonics.com Laser Photonics Corporation (NASDAQ: LASE)...
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results
Phase 1/2 study of KB-0742 is on track to clear 80mg four-days-on, three-days-off schedule in the third quarter of 2024;...
KIRKLAND’S HOME REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS
NASHVILLE, Tenn., March 21, 2024 /PRNewswire/ -- Kirkland's, Inc. (Nasdaq: KIRK) ("Kirkland's Home" or the "Company"), a specialty retailer of...
Charlotte’s Web Reports 2023 Fourth Quarter and Year-End Financial Results
Transforming the consumer journey through eCommerce platform optimizations, brand consolidation, and price recalibrations; While reducing expenses and maintaining gross margins ...
MiNK Reports Fourth Quarter and Year-End 2023 Results
NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,...
Immatics Announces Full Year 2023 Financial Results and Corporate Update
Houston, Texas and Tuebingen, Germany, March 21, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in...
InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
JENA, Germany, March 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biotechnology company pioneering anti-inflammatory therapeutics by targeting...
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage biotechnology company developing anti-fibrotic therapeutics...
Gogo Conducting 5G Software Testing with State-of-the-Art Virtual Flight Simulator
Gogo 5G Remains on Track for Expected Commercial Launch Later This Year DALLAS, March 21, 2024 /PRNewswire/ -- (AEA, Booth...
Gambling.com Group Q4 Revenue Rises 52% to a Quarterly Record $32.5 Million
Generates Q4 Net Income of $6.4 Million and a 54% Increase in Adjusted EBITDA to $10.6 Million 2023 Full Year...
Exscientia Business and Financial Update for the Full Year 2023
Contacts Investor Relations: Sara Sherman / Chinedu Okeke investors@exscientia.ai Media: Oliver Stohlmann media@exscientia.ai Exscientia plc (Nasdaq: EXAI) Recent advancements in...